SCHEMBL24738579

SCHEMBL24738579

N#Cc1ccc(-c2c(-n3c4ccc(-c5ccccc5C#N)cc4c4cc(-c5ccccc5C#N)ccc43)cncc2-n2c3ccc(-c4ccccc4C#N)cc3c3cc(-c4ccccc4C#N)ccc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.42
TRPA1 O75762 1/20 0.40
CYP1A2 P05177 6/20 0.40
CYP3A4 P08684 6/20 0.40
HSD17B10 Q99714 4/20 0.40
HPGD P15428 3/20 0.40
KDM4E B2RXH2 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 1/20 0.40
ALDH1A1 P00352 4/20 0.39
CLK4 Q9HAZ1 3/20 0.39
MAPK1 P28482 1/20 0.39
ALOX5AP P20292 1/20 0.38
FEN1 P39748 1/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37
CYP2C19 P33261 2/20 0.37
ESR2 Q92731 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24738575 0.97 TRPA1 (0.40) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL21929205 0.91 NR3C1 (0.40) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL21929086 0.91 PRMT5 (0.37) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL24738577 0.91 TRPA1 (0.43) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL21931843 0.90 NR3C1 (0.45) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL24738574 0.90 TRPA1 (0.40) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL21928454 0.90 NR3C1 (0.40) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL21931766 0.89 PRMT5 (0.41) NR3C1PRMT5WDR77CYP11B1CYP11B2
SCHEMBL21928636 0.89 PRMT5 (0.38) NR3C1TRPA1CYP1A2CYP3A4HSD17B10
SCHEMBL24737368 0.88 TRPA1 (0.39) NR3C1TRPA1CYP1A2CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES CYNORA GMBH (DE) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388960-A1 ORGANIC MOLECULES FOR USE IN LIGHT-EMITTING DEVICES ALDH1A2, AOX1, CYBA NR3C1 3420/4885TRPA1 33/4885CYP1A2 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.